ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Evofem Biosciences Inc

Evofem Biosciences Inc (EVFM)

0.4782
0.00
(0.00%)
Closed February 09 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.4782
Bid
0.465
Ask
0.468
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.4782
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,680,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
8.8
Revenue
18.22M
Net Profit
50M

About Evofem Biosciences Inc

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

EVFM Latest News

Biopharma Partners with Telemed Firm and Shares are Climbing

This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

Evofem Biosciences Announces Cost Reduction Measures

Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

Evofem Biosciences Appoints Interim Chief Financial Officer

Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

Costco Adds Phexxi® to Member Prescription Program

Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EVFM - Frequently Asked Questions (FAQ)

What is the current Evofem Biosciences share price?
The current share price of Evofem Biosciences is US$ 0.4782
How many Evofem Biosciences shares are in issue?
Evofem Biosciences has 5,680,000 shares in issue
What is the market cap of Evofem Biosciences?
The market capitalisation of Evofem Biosciences is USD 2.72M
What is the 1 year trading range for Evofem Biosciences share price?
Evofem Biosciences has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the cash to sales ratio of Evofem Biosciences?
The cash to sales ratio of Evofem Biosciences is 0
What is the reporting currency for Evofem Biosciences?
Evofem Biosciences reports financial results in USD
What is the latest annual turnover for Evofem Biosciences?
The latest annual turnover of Evofem Biosciences is USD 18.22M
What is the latest annual profit for Evofem Biosciences?
The latest annual profit of Evofem Biosciences is USD 50M
What is the registered address of Evofem Biosciences?
The registered address for Evofem Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Evofem Biosciences website address?
The website address for Evofem Biosciences is www.evofem.com
Which industry sector does Evofem Biosciences operate in?
Evofem Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
780.46M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
140.32M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
215.16M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
72.39M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.28M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.15M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
47.43M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.4M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.08M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
212.29M

Discussion

View Full Feed
LVerstee LVerstee 6 minutes ago
A perfect description of yourself. Couldn't be more to the point.

But there is one thing I have learned through the years. Which is that the so-called "critics" out there will never be satisfied no matter how much evidence you shove down their throats.

These people wil
ITUP
FUNYMUNY FUNYMUNY 7 minutes ago
They will just keep milking the sheep that buy into this failure. They have NOTHING but shares to sell. Buyer beware
PPCBD
SEV123 SEV123 9 minutes ago
And yet my friend, once again you refuse to answer what's more important. You said something was coming but you've made promises in the past as Future and as Silicon and nothing has ever come of it.
SEV
Idiot Mayor Idiot Mayor 12 minutes ago
FIVE…… FIVE MORE DAYS!!! On Friday, you will either be vindicated or you will be buried. On Monday you will either be broke and FRANTICALLY seeking a new, plausible explanation to keep the desperate hope alive or you will be counting your billions as the naked shorts scramble to cover this up to dol
DBMM
Bob Mullet Bob Mullet 23 minutes ago
Still posting the Boiler Room party line?

People laugh at you 🤦🏻‍♂️ 

Keep it up!!?!
KBLB
Bull_Dolphin Bull_Dolphin 23 minutes ago
Good morning Larry, another great day!
Bull_Dolphin Bull_Dolphin 24 minutes ago
Stephen Miller goes off:

https://x.com/JackPosobiec/status/1887970744526569638
SkeBallLarry SkeBallLarry 26 minutes ago
" a Brilliant move ~ Good Sabbath Morn', Bull "
vator vator 52 minutes ago
style="caret-color: rgb(0, 29, 53); color: rgba(0, 29, 53, 1); font-family: "Google Sans", Roboto, "Helvetica Neue", sans-serif; font-size: 18px"an estimated 704,000 new cancer cases are expected in Brazil eac
NWBO
thecrusher2011 thecrusher2011 2 hours ago
Oh now you've hurt my feelings. Not trying to brag or anything but I'll have you know I went to Tijuana once
marcis marcis 2 hours ago
This is exactly your motivation here.
500 million borrowed ( short ) shares, sell two tick down to .0006 is already is a fast $100,000

Down to 4 or 5 you get a big bonus plus

No wonder the passion to be on your point all weekend and night

I say t
RDAR
Testpilot Testpilot 2 hours ago
I see that sales only dropped by .46%, however the operating income, Net income from continuing operation before income tax, along with Net income fell by -22.99%, -88.36%, and -94.40% respectively. The company submitted a vague explanation "Recognizing subsidiary equity loss and impairment" as to
CRTG
nshi2 nshi2 2 hours ago
https://youtu.be/2xE4bopeXhw
LWLG
thecrusher2011 thecrusher2011 2 hours ago
😂😂😂😂 you're still mad that I noticed all liberals are feminine
Louinjaxxx Louinjaxxx 2 hours ago
A friend of mine wrote a book on TA (Technical Analysis).  It was his opinion, and I agree with him, that TA and charting is worthless when dealing with penny stocks and especially with sub-penny stocks.
AXXA
LVerstee LVerstee 2 hours ago
I’ll wait. You either missed it or chose not to acknowledge it. Your insults don’t affect me, and I won’t take any satisfaction when you eventually understand what I mean. Not with you.
You showed one half of the evidence and you can't even tell yourself.
All you’ve proven is that you
ITUP
DMC8 DMC8 2 hours ago
https://www.sciencedirect.com/science/article/pii/S104366182500060X
AMRN
jeunke22 jeunke22 2 hours ago
One would imagine these guys have business plans in place and are aware of the critical success factors. I guess Deep Seek was a wake up call to keep an eye on capex, costs , power and sustainability.
For me Lightwave’s value propositions are becoming more solid going forward. Enjoy the Super
LWLG
theswordman theswordman 2 hours ago
What exactly was his contribution on those papers that had him listed as an author?

What exactly was his contribution on EVERY SEC filing that had him listed as CEO?

Absolutely nothing--say it again (What is IT good for?) Absolutely nothing

Leronlimab des
CYDY
janice shell janice shell 2 hours ago
Impressive!

https://x.com/gunsnrosesgirl3/status/1888500878446887109
janice shell janice shell 2 hours ago
Why do these kinds of people never seem to understand they look like incels playing dress-up?

They get home and Mom asks, "What?? You BURNED that outfit I spend two days making for you??"
janice shell janice shell 2 hours ago
Oh yes, Two hundred years of brilliant Russian novels. Similar to our own tradition in its quality and duration, really, except that none of our authors were ever sent off to the Gulag. The military, yes, but not political prison camps. However, it's a bit late to enter on a discussion of comparativ

Your Recent History

Delayed Upgrade Clock